HEATR5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.854600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.065000E-01
Normal-vs-Stage2
2.835200E-01
Normal-vs-Stage3
4.491800E-02
Normal-vs-Stage4
2.290600E-01
Stage1-vs-Stage2
4.409800E-01
Stage1-vs-Stage3
5.289600E-02
Stage1-vs-Stage4
8.267200E-01
Stage2-vs-Stage3
2.724200E-02
Stage2-vs-Stage4
7.490400E-01
Stage3-vs-Stage4
7.447900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.896600E-01
Normal-vs-AfricanAmerican
1.371380E-01
Normal-vs-Asian
2.220800E-01
Caucasian-vs-AfricanAmerican
9.278200E-01
Caucasian-vs-Asian
1.722000E-01
AfricanAmerican-vs-Asian
3.324800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.732800E-01
Normal-vs-Female
3.008400E-01
Male-vs-Female
3.802200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.080800E-01
Normal-vs-Age(41-60Yrs)
3.488200E-01
Normal-vs-Age(61-80Yrs)
2.587200E-01
Normal-vs-Age(81-100Yrs)
3.991600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.416000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.986800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.438800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.304260E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.121800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.086000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.749800E-01
Normal-vs-Daily Drinker
1.833940E-02
Normal-vs-Weekly Drinker
1.601890E-02
Normal-vs-Occasional Drinker
9.969700E-02
Normal-vs-Social Drinker
2.879600E-01
Non Drinker-vs-Daily Drinker
7.626800E-01
Non Drinker-vs-Weekly Drinker
2.528400E-01
Non Drinker-vs-Occasional Drinker
2.231000E-01
Non Drinker-vs-Social Drinker
8.454200E-01
Daily Drinker-vs-Weekly Drinker
4.555000E-01
Daily Drinker-vs-Occasional Drinker
2.050400E-01
Daily Drinker-vs-Social Drinker
6.760800E-01
Weekly Drinker-vs-Occasional Drinker
7.734200E-02
Weekly Drinker-vs-Social Drinker
2.485600E-01
Occasional Drinker-vs-Social Drinker
3.811600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.832200E-02
Normal-vs-Grade 2
7.124400E-03
Normal-vs-Grade 3
1.259110E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.044000E-01
Grade 1-vs-Grade 3
8.576800E-01
Grade 1-vs-Grade 4
4.832200E-02
Grade 2-vs-Grade 3
6.331400E-01
Grade 2-vs-Grade 4
7.124400E-03
Grade 3-vs-Grade 4
1.259110E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.699200E-01
Normal-vs-NonDiabetic
2.688800E-01
Diabetic-vs-NonDiabetic
9.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.603000E-01
Normal-vs-NoPancreatitis
2.686400E-01
Pancreatitis-vs-NoPancreatitis
7.981400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.337600E-02
Normal-vs-N1
2.854400E-01
N0-vs-N1
7.517400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.050800E-01
Normal-vs-TP53-NonMutant
3.919000E-01
TP53-Mutant-vs-TP53-NonMutant
1.011980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
